Company

Excyte Biopharma

As of the edition of 20 October 2026, Excyte Biopharma runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active2
Total2

Where its trials are

  • Immune system: 5 trials led
  • Blood and lymph: 4 trials led
  • Cancer: 4 trials led